Lipotropics
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
| Generic Name | Brand Name | Form | PDL Status |
Current Drug Use Criteria | New Drug Evaluation |
|---|---|---|---|---|---|
| chondroitin sulfate A | CHONDROITIN SULFATE | CAPSULE | |||
| krill/omega-3/dha/epa/lipids | KRILL OIL | CAPSULE | |||
| lecithin | LECITHIN | CAPSULE | |||
| omega-3 fatty acids | FISH OIL | CAPSULE | |||
| omega-3 fatty acids/fish oil | FISH OIL | CAPSULE | |||
| omega-3 fatty acids/fish oil | FISH OIL | CAPSULE DR | |||
| omega-3/dha/epa/fish oil | FISH OIL OMEGA-3 | CAPSULE | |||
| omega-3/dha/epa/fish oil | FISH OIL | CAPSULE | PA Document | ||
| omega-3/dha/epa/fish oil | OMEGA-3 FISH OIL | CAPSULE DR | |||
| omega-3/dha/epa/fish oil | FISH OIL | CAPSULE DR |